| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |